Brii Biosciences Limited

Direct answer

Brii Biosciences Limited is publicly traded on HKSE under the ticker 2137.HK.

Founded in Beijing, China, in 2017, Brii Biosciences Limited is a biopharmaceutical firm dedicated to discovering and developing innovative therapies for infectious diseases and central nervous system disorders. Its diverse pipeline features: early-stage (Phase 1) compounds BRII-778 and BRII-732 for treating HIV; a multifaceted approach to Hepatitis B (HBV) including a Phase 2 combination study of BRII-179 and...

Can you invest in Brii Biosciences Limited?

Yes. Brii Biosciences Limited is publicly traded on HKSE under the ticker 2137.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Brii Biosciences Limited

Detailed equity research is provided by MarketSnap.